A rare diagnosis with a common presentation: a case report on uterine sarcoma

Rinda Naidu Kanukolanu; Ushadevi Gopalan; Sivan Kumar Kumarapillai; Priyanka P.

doi:10.18203/2320-1770.ijrcog20212202

Authors

Rinda Naidu Kanukolanu Department of Obstetrics and Gynecology, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Chengalpattu District, Tamil Nadu, India
Ushadevi Gopalan Department of Obstetrics and Gynecology, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Chengalpattu District, Tamil Nadu, India
Sivan Kumar Kumarapillai Department of Obstetrics and Gynecology, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Chengalpattu District, Tamil Nadu, India
Priyanka P. Department of Obstetrics and Gynecology, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Chengalpattu District, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20212202

Keywords:

Uterine sarcoma, Postmenopausal, Utero vaginal prolapse

Abstract

Uterine sarcomas are rare soft tissue tumors which constitute 3% to 7% of overall uterine malignancies. Endometrial stromal sarcoma (ESS) is a rare type of uterine sarcoma arising from the mesodermal component of the body of the uterus. It constitutes around 0.2% of all the uterine tumors. It primarily occurs in perimenopausal women. One third of cases are seen in postmenopausal women. The presentation is not very different from an abnormal uterine bleeding, abdominal pain or a mass effect. Here we discuss an interesting case of 70 years female with a very common presentation of utero-vaginal prolapse but turned out to be a very rare postoperative diagnosis of uterine sarcoma.

Metrics

Metrics Loading ...

References

Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116(1):131-9.

Skorstad M, Kent A, Lieng M. Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study. Acta Obstet Gynecol Scand. 2016;95(11):1228-34.

Kvale G, Heuch I, Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res. 1988;48(21):6217-21.

Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009;104(3):177-8.

Prat J, Mbatani. Uterine sarcomas. Int J Gynaecol Obstet. 2015;131(2):105-10.

Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol. 2011;25(6):681-9.

Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging. 2004;20(6):998-1007.

Trope CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012;51(6):694-705.

Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145(1):208-16.

Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine Adenosarcoma: a Review. Curr Oncol Rep. 2016;18(11):68.

Benson C, Miah AB. Uterine sarcoma- current perspectives. Int J Womens Health. 2017;9:597-606.